Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | PLG | P00747 | 2/20 | 0.46 |
| ▸ | KLK1 | P06870 | 2/20 | 0.46 |
| ▸ | KLK6 | Q92876 | 2/20 | 0.46 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.46 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL21192808 | 0.97 | HRH3 (0.48) | HRH3LOXL2TSHRPLGKLK1 | |
| Bromide SCHEMBL29220646 | 0.97 | HRH3 (0.48) | HRH3LOXL2TSHRPLGKLK1 | |
| SCHEMBL16344083 | 0.93 | HRH3 (0.64) | HRH3LOXL2TSHRPLGKLK1 | |
| SCHEMBL8404395 | 0.83 | HRH3 (0.55) | HRH3LOXL2ABATCA1CA2 | |
| SCHEMBL29304338 | 0.82 | BCHE (0.45) | LOXL2PLGKLK1KLK6KLKB1 | |
| SCHEMBL7989533 | 0.82 | HRH3 (0.48) | HRH3LOXL2ABATKIF11TAAR1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28577312 | 0.81 | CA1 (0.43) | PLGKLK1KLK6KLKB1BCHE | |
| SCHEMBL23352980 | 0.80 | HRH3 (0.46) | HRH3LOXL2PLGKLK1KLK6 | |
| SCHEMBL4825874 | 0.80 | ABAT (0.48) | HRH3LOXL2PLGKLK1KLK6 | |
| SCHEMBL20767068 | 0.80 | LOXL2 (0.48) | HRH3LOXL2ABATKIF11TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094389-A | Perovskite material, perovskite layer, preparation method of perovskite layer, perovskite solar cell and photovoltaic module | — | 2026-05-26 | — | — | CN | claimed |
| US-20260047329-A1 | METHOD OF PREPARING SINGLE CRYSTAL PEROVSKITE AND METHOD OF MANUFACTURING SOLAR CELL USING SINGLE CRYSTAL PEROVSKITE | KOREA ELECTRIC POWER CORP (KR) | 2026-02-12 | — | — | US | claimed |
| US-20250361545-A1 | LABEL, MARKER AND METHOD FOR ANALYZING A BIOLOGICAL SAMPLE | LEICA MICROSYSTEMS (DE) | 2025-11-27 | — | — | US | claimed |
| US-20250362289-A1 | LABEL, MARKER AND METHOD FOR ANALYZING A BIOLOGICAL SAMPLE | LEICA MICROSYSTEMS (DE) | 2025-11-27 | — | — | US | claimed |
| EP-4653543-A1 | A LABEL, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE | Leica Microsystems CMS GmbH (DE) | 2025-11-26 | — | — | EP | claimed |
| EP-4653544-A1 | A LABEL, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE | Leica Microsystems CMS GmbH (DE) | 2025-11-26 | — | — | EP | claimed |
| US-12473660-B2 | Method of preparing single crystal perovskite and method of manufacturing solar cell using single crystal perovskite | KOREA ELECTRIC POWER CORPORATION (KR) | 2025-11-18 | — | — | US | claimed |
| CN-114420852-B | Preparation method of pure-phase RP perovskite film | 河北工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119912457-A | Pyrimidine triazole compound as well as preparation method and application thereof | 郑州大学 | 2025-05-02 | — | — | CN | claimed |
| CN-114824092-B | Solar cell based on quasi-two-dimensional perovskite and preparation method thereof | 北京炎和科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| EP-1412328-B1 | DOLASTATIN 10 DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-10-04 | — | — | EP | claimed |
| US-6737409-B2 | FOR CANCER THERAPY | HOFFMANN-LA ROCHE INC. | 2004-05-18 | — | — | US | claimed |
| EP-1412328-A1 | DOLASTATIN 10 DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2004-04-28 | — | — | EP | claimed |
| US-6586459-B2 | Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide | BEIGHT DOUGLAS WADE (US) | 2003-07-01 | — | — | US | claimed |
| US-20030055002-A1 | Dolastatin 10 derivatives | HOFFMANN-LA ROCHE INC. | 2003-03-20 | — | — | US | claimed |
| WO-2003008378-A1 | DOLASTATIN 10 DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2003-01-30 | — | — | WO | claimed |
| EP-0635508-B1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | ASAHI CHEMICAL IND (JP) | 1999-10-06 | — | — | EP | claimed |
| US-5621103-A | 3-(SUBSTITUTED METHYLAMINOCARBONYL)-1,2,3,4-TETRAHYDRO-(1)BENZOTHIENO(2,3-C) PYRIDINES; ANXIOLYTIC AGENTS; LEARNING ENHANCEMENT | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-04-15 | — | — | US | claimed |
| EP-0635508-A1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1995-01-25 | — | — | EP | claimed |
| WO-1994005642-A1 | INDAZOLE DERIVATIVES | CIBA-GEIGY AG (CH) | 1994-03-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055002-A1 | Dolastatin 10 derivatives | DAD1, DDOST, NPC1 | HRH3 4452/4885LOXL2 3010/4885TSHR 4777/4885 |
| US-20260047329-A1 | METHOD OF PREPARING SINGLE CRYSTAL PEROVSKITE AND METHOD OF MANUFACTURING SOLAR CELL USING SINGLE CRYSTAL PEROVSKITE | TMCO1, SLC7A5, SLC43A1 | HRH3 3402/4885LOXL2 4489/4885TSHR 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.